Company BIGN HLDG

Equities

BTH

AU000000BTH6

Delayed Australian S.E. Other stock markets 23:17:09 2024-06-27 EDT			5-day change	1st Jan Change
0.1 ^AUD	0.00%		-9.09%	-50.00%

06-20	Bigtincan Holdings Rejects Vector's Revised Acquisition Offer	MT
06-12	US Inflation, Policy Announcement Jitters Suppress Appetite for Australian Shares	MT

Business Summary

Beta Pharmaceutical Limited is a Australia-based biopharmaceutical company. The Company is focused on the identification, development and commercialization of products and therapies targeting the chemoprevention and treatment of breast cancer. The Company is working in collaboration with scientists at the College of Pharmacy, University of Louisiana at Monroe in southern the United States of America (ULM) to develop cancer chemopreventive agents using natural phytonutrients, called tocotrienols as treatments for breast cancers. Funded by Beta Pharmaceutical Limited, the applied research programme with ULM includes four laboratories and is known as the Breast Cancer and Health Project, which has been underway.

Number of employees: 495

Sales per Business

AUD in Million	2022	Weight	2023	Weight	Delta
Subscription and Support Services 93.8 %	102	94.4 %	115	93.8 %	+12.54%
Professional and Contract Services 6.2 %	6	5.6 %	8	6.2 %	+26.07%

Sales per region

AUD in Million	2022	Weight	2023	Weight	Delta
United States 83.3 %	94	86.6 %	102	83.3 %	+8.99%
Rest of the World 12.1 %	10	9.5 %	15	12.1 %	+43.84%
Australia 4.6 %	4	3.9 %	6	4.6 %	+34.36%

Managers

Managers	Title	Age	Since
David Keane FOU	Founder	-	10-12-31
Patrick Welch PSD	President	-	11-12-31
Vivian Stewart COO	Chief Operating Officer	-	14-10-31
Stefan Teulon PRN	Corporate Officer/Principal	-	-
Cyril Desouza AUD	Comptroller/Controller/Auditor	-	-
Kent Erickson PRN	Corporate Officer/Principal	-	18-04-04

Members of the board

Members of the board	Title	Age	Since
Inese Kingsmill BRD	Director/Board Member	-	21-10-05
Wayne Stevenson BRD	Director/Board Member	-	16-09-27
David Keane FOU	Founder	-	10-12-31
Thomas Amos CHM	Chairman	-	16-09-27

Shareholders

Name	Equities	%	Valuation
Regal Funds Management Pty Ltd. 18.50 %	113,999,655	18.50 %	11 M $
Australian Ethical Investments Ltd. (Investment Management) 13.37 %	82,398,877	13.37 %	8 M $
SQN Investors LP 12.16 %	74,940,121	12.16 %	7 M $
MA Investment Management Pty Ltd. 4.473 %	27,563,168	4.473 %	3 M $
David Keane 3.852 %	23,740,992	3.852 %	2 M $
Lai Sun Keane 2.307 %	14,217,541	2.307 %	1 M $
Estate of Cohen Geoffrey 1.145 %	7,053,875	1.145 %	656 786 $
Aotearoa Investment Co. Pty Ltd. 0.7838 %	4,830,014	0.7838 %	449 723 $
SBCVC Fund IV Pte Ltd. 0.5619 %	3,462,784	0.5619 %	322 420 $
Southern Cross Iif Trusco Pty Ltd. 0.5210 %	3,210,380	0.5210 %	298 918 $